Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B2bdfe067e9445c1749cb65a79027feaf> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B2bdfe067e9445c1749cb65a79027feaf NCIT_P378 "NCI" @default.
- B2bdfe067e9445c1749cb65a79027feaf type Axiom @default.
- B2bdfe067e9445c1749cb65a79027feaf annotatedProperty IAO_0000115 @default.
- B2bdfe067e9445c1749cb65a79027feaf annotatedSource NCIT_C172997 @default.
- B2bdfe067e9445c1749cb65a79027feaf annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with crizotinib in patients with tumors that have ALK translocations, excluding adenocarcinomas of lung and anaplastic large cell lymphomas." @default.